How FDA panelists casting doubt on antidepressant use during pregnancy could lead to devastating outcomes for mothers
- Written by Nicole Amoyal Pensak, Researcher of Caregiver Stress Management and Clinical Psychologist, University of Colorado Anschutz Medical Campus
Research shows that the risks of untreated depression in pregnancy is much larger than the risks posed by SSRIs. RyanKing999/iStock via Getty Images PlusAt a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the safety of antidepressant medications called selective serotonin reuptake...